Vijay Vaswani
Barcelona, Spain
Omniscope is not a venture capital firm but rather a biotechnology/healthtech company focused on immune system analysis and personalized medicine. They develop AI-driven immune decoding technologies to explore and interpret immune system activity across sports performance, longevity, and pharmaceutical applications. Their platform leverages T cell tracking and cellular avatars to optimize healthspan, boost athletic performance, and engineer therapeutic solutions.
